Cancer

Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

Study Demonstrated a Sensitivity of 100% and Specificity of 95%Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular…

3 months ago

Sapu Nano Unveils First-in-Human Clinical Trial of Sapu-003 at 8th Australian Translational Breast Cancer Research Symposium

Using Sapu Nano’s proprietary Deciparticle™ technology, Sapu-003 delivers everolimus intravenouslySYDNEY, Australia, Oct. 08, 2025 (GLOBE NEWSWIRE) -- via IBN –…

3 months ago

Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement

Catalent gains global rights to evaluate certepetide and its analogs for use as SMARTag® payloads across multiple ADCs designed to…

3 months ago

Evaxion expands AI-Immunology™ platform with automated vaccine design module

New platform module automates previous manual vaccine design processes, improving quality and dramatically reducing time and resource requirementsAI-Immunology™, already superior…

3 months ago

Starton Therapeutics to Share Innovative Lenalidomide Delivery Technology on Labroots Webinar Sponsored by Primetech Corporation

PARAMUS, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with…

3 months ago

PromoCell Expands Partnership With Bioz to Empower Researchers With Enhanced Scientific Insights

PALO ALTO, CALIFORNIA / ACCESS Newswire / October 8, 2025 / Bioz, Inc, a pioneer in AI-driven citation management, is…

3 months ago

Angle PLC Announces Strategy Update

Appointment of Executive Chairman, proposed change of name and strategy updateCompany to pursue revised strategy and name change to CelLBxHealth…

3 months ago

PowerPay Partners with Alex’s Lemonade Stand Foundation to Support Childhood Cancer Research

WAYNE, Pa., Oct. 7, 2025 /PRNewswire/ -- PowerPay, an AI-driven financing platform providing consumers with home improvement and patient financing, has…

3 months ago

NEW RESEARCH FROM END WELL REVEALS TELEVISION SPARKS END-OF-LIFE CONVERSATIONS: VIEWERS SIGNIFICANTLY MORE LIKELY TO DISCUSS MORTALITY AFTER WATCHING AUTHENTIC STORYLINES

90% of Americans say end-of-life conversations are important, yet only 27% have had them - television storytelling emerges as a…

3 months ago

Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit

ATLANTA, GEORGIA / ACCESS Newswire / October 7, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company…

3 months ago